Neoadjuvant chemotherapy alone with mFOLFOXIRI in locally advanced rectal cancer: A single-arm phase II study.

被引:0
|
作者
Deng, Yanhong [1 ]
Zhang, Jianwei [1 ]
Cai, Yue [1 ]
Hu, Huabin [1 ]
Ling, Jiayu [1 ]
Xiao, Jian [1 ]
Huang, Meijin [1 ]
Kang, Liang [1 ]
Wang, Lei [1 ]
Lan, Ping [1 ]
Wang, Jianping [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China
关键词
D O I
10.1200/jco.2016.34.4_suppl.tps783
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS783
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy for locally advanced rectal cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (10): : 876 - 876
  • [32] Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
    Papaccio, Federica
    Rosello, Susana
    Huerta, Marisol
    Gambardella, Valentina
    Tarazona, Noelia
    Fleitas, Tania
    Roda, Desamparados
    Cervantes, Andres
    CANCERS, 2020, 12 (12) : 1 - 12
  • [33] Apatinib plus SOX regimen as neoadjuvant chemotherapy for locally advanced gastric cancer: A phase II study.
    Zheng, Ya'nan
    Yang, Xiao
    Shi, Hongpeng
    Yang, Zhongyin
    Yan, Chao
    Ni, Zhentian
    Li, Mengjiao
    Sah, Birendra Kumar
    Liu, Wentao
    Xu, Wei
    Yao, Xuexin
    Zhu, Zhenglun
    Yan, Min
    Zhu, Zhenggang
    Li, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Neoadjuvant chemoradiation in locally advanced rectal cancer: Results of a phase II study
    Delrio, P
    Avallone, A
    Guida, C
    Marone, P
    Petrillo, A
    Tatangelo, F
    Di Marzo, M
    Scala, D
    Parisi, V
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S115 - S115
  • [35] Neoadjuvant chemoradiation in locally advanced rectal cancer: Results of a phase II study
    P. Delrio
    A. Avallone
    C. Guida
    P. Marone
    A. Petrillo
    F. Tatangelo
    M. Di Marzo
    D. Scala
    V. Parisi
    Annals of Surgical Oncology, 2004, 11 : S115 - S115
  • [36] Totally neoadjuvant chemoradiation therapy with mFOLFOX6 in locally advanced rectal cancer: A single arm phase II study (FOTAC).
    Zhang, Jianwei
    Cai, Yue
    Hu, Huabin
    Xiao, Jian
    Chen, Dianke
    Ling, Jiayu
    Huang, Meijin
    Wang, Lei
    Kang, Liang
    Lan, Ping
    Wang, Jianping
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [37] Camrelizumab in combination with preoperative chemotherapy for locally advanced esophageal squamous cell carcinoma: A single-arm, open-label, phase II study.
    Wang, Feng
    Qi, Yu
    Meng, Xiangrui
    Fan, Qingxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial
    Zheng, Rong
    Wang, Bi-Si
    Li, Zhihua
    Chi, Pan
    Xu, Benhua
    BMJ OPEN, 2023, 13 (03):
  • [39] Phase II Trial of Neoadjuvant Chemotherapy with XELOX plus Bevacizumab for Locally Advanced Rectal Cancer
    Uehara, Keisuke
    Ishiguro, Seiji
    Sakamoto, Eiji
    Maeda, Atsuyuki
    Inoue, Masaya
    Tojima, Yuichiro
    Kobayashi, Satoshi
    Omiya, Naoki
    Ishizuka, Naoki
    Nakao, Akimasa
    Goto, Hidemi
    Nagino, Masato
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 1041 - 1044
  • [40] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)